secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2024-02-20T23:59:59+00:00
Accession:  0001493152-24-007222
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Chairman Gary Jacob resigns from Hepion board; John Brancaccio appointed Chairman
--------------------------------------------------------------------------------

- Dr. Gary Jacob resigned as Chairman and from the Board on February 20, 2024, for personal reasons.
- Board appointed John Brancaccio as new Chairman effective immediately.
- John Cavan continues as Interim CEO and CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000149315224007222/0001493152-24-007222-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000149315224007222/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-007222

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer